Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01530971
Other study ID # 10AS00008/044/10
Secondary ID
Status Completed
Phase Phase 3
First received February 8, 2012
Last updated July 1, 2013
Start date March 2012
Est. completion date March 2013

Study information

Verified date June 2013
Source Mahidol University
Contact n/a
Is FDA regulated No
Health authority Thailand: Ethical Committee
Study type Interventional

Clinical Trial Summary

Intraoperative supplemental oxygen has been given for most parturients undergoing cesarean section under spinal anesthesia. However, evidences supporting the practice is not clear nowadays, especially for healthy parturients who are monitored continuously with pulse oximeter. Furthermore, hyperoxia may produce free radicles which could harm fetus and newborns.

Changing practice is not that easy. This study has been conducted to prove that supplemental oxygen is not necessary for healthy parturients during cesarean section.


Description:

Supplemental oxygen has been routinely given to parturients because doctors were concerned about desaturation. However, the evidences for giving oxygen was not strong, and the condition nowadays can be detected immediately with pulse oximeter which is a standard monitoring.

After this study finished, we will set a safety guideline for supplemental oxygen for healthy parturients undergoing elective cesarean section.


Recruitment information / eligibility

Status Completed
Enrollment 325
Est. completion date March 2013
Est. primary completion date March 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 19 Years and older
Eligibility Inclusion Criteria:

- Aged > 18 years old.

- Term pregnancy (gestational age 37 -42 weeks).

- Singleton

- Elective cesarean section.

Exclusion Criteria:

- History of infertility

- Diabetes

- Hypertension or preeclampsia

- Heart disease

- Morbid obesity

- Premature rupture of membrane

- Placenta previa

- Preoperative oxygen saturation < 95%

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Supplemental 3LPM oxygen via canula
Parturients will receive supplemental oxygen (3LPM) via nasal canula

Locations

Country Name City State
Thailand Siriraj hospital Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Mahidol University

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary proportion of maternal desaturation Oxygen saturation < 94% once. intraoperative period Yes
Secondary neonatal outcomes Apgar score and parameters from umbilical cord gas intraoperative period Yes
See also
  Status Clinical Trial Phase
Completed NCT02816281 - Scheduled Elective Surgical Case Cancellation in Siriraj: Evaluation and Identification of the Reasons N/A
Completed NCT03432143 - Community Members as Reviewers of Medical Journal Manuscripts N/A
Completed NCT02486016 - Transdermal Patch CVD 2000: The Effect of Heat on Fentanyl Release From Fentanyl TDSs in Healthy Adults Phase 4
Completed NCT02531971 - Fentanyl Patch Pharmacokinetics in Healthy Adults Phase 4
Terminated NCT02411734 - Effect of Executive Dysfunction on Rehabilitation Potential N/A